VanEck Associates
OGN icon

VanEck Associates’s Organon & Co OGN Stock Holding History

VanEck Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Sell
158,117
-44,559
-22% -$533K ﹤0.01% 1025
2026
Q1 		$1.21M Buy
202,676
+6,270
+3% +$47.2K ﹤0.01% 1057
2025
Q4 		$1.41M Buy
196,406
+104,394
+113% +$825K ﹤0.01% 1042
2025
Q3 		$983K Sell
92,012
-15,439
-14% -$152K ﹤0.01% 1088
2025
Q2 		$1.04M Sell
107,451
-635,968
-86% -$6.56M ﹤0.01% 1045
2025
Q1 		$11.1M Buy
743,419
+213,937
+40% +$3.29M 0.01% 451
2024
Q4 		$7.9M Buy
529,482
+252,750
+91% +$4.12M 0.01% 534
2024
Q3 		$4.76M Buy
276,732
+67,451
+32% +$1.4M 0.01% 663
2024
Q2 		$4.33M Buy
209,281
+37,371
+22% +$743K 0.01% 629
2024
Q1 		$3.23M Sell
171,910
-73,681
-30% -$1.26M ﹤0.01% 724
2023
Q4 		$3.54M Sell
245,591
-57,588
-19% -$783K 0.01% 638
2023
Q3 		$5.26M Sell
303,179
-91,614
-23% -$1.91M 0.01% 490
2023
Q2 		$8.22M Buy
394,793
+130,590
+49% +$2.84M 0.02% 385
2023
Q1 		$6.21M Sell
264,203
-192,039
-42% -$5.16M 0.01% 439
2022
Q4 		$12.7M Buy
456,242
+42,464
+10% +$1.09M 0.03% 303
2022
Q3 		$9.68M Sell
413,778
-195,486
-32% -$5.9M 0.03% 314
2022
Q2 		$20.6M Buy
609,264
+281,032
+86% +$9.84M 0.05% 239
2022
Q1 		$11.5M Sell
328,232
-9,306
-3% -$318K 0.02% 345
2021
Q4 		$10.3M Buy
337,538
+41,705
+14% +$1.36M 0.02% 370
2021
Q3 		$9.7M Buy
295,833
+106,368
+56% +$3.4M 0.02% 346
2021
Q2 		$5.73M Buy
+189,465
New +$6.24M 0.01% 442

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

VanEck Associates's OGN Position: Q2 2026 in Review

VanEck Associates reduced its Organon & Co (OGN) stake by 22% in Q2 2026, selling an estimated $533K and leaving 158,117 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

VanEck Associates first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $20.6M in Q2 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • VanEck Associates held 158,117 shares of Organon & Co worth $2.14M as of Q2 2026.
  • VanEck Associates sold 44,559 Organon & Co shares in Q2 2026, an estimated $533K.
  • Organon & Co made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1025 holding.
  • VanEck Associates first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • VanEck Associates's Organon & Co position peaked at $20.6M in Q2 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.